Long-term outcome of patients with myeloid malignancies (acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndrome), with and without KIR ligand incompatibility. (A) Kaplan-Meier estimates for the probability of overall survival. (B) Kaplan-Meier estimates for the probability of disease-free survival. (C) Cumulative incidence estimates for the probability of relapse. (D) Cumulative incidence estimates for the probability of transplant-related mortality.